Prescribing of antivirals for COVID-19 in a South Australian local health network according to statewide guidelines
© 2023 Royal Australasian College of Physicians..
Antiviral drugs were rapidly implemented into clinical practice for the treatment of high-risk patients with COVID-19, prompting the development of statewide guidelines. This South-Australian study reviewed guideline adherence, assessed prescribing patterns and highlighted the inappropriate management of relative drug-drug interactions and dosing for renal function. Additionally, it evaluated the impact of inappropriate antiviral drug use and suggested methods to improve quality use of medicines.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:54 |
|---|---|
| Enthalten in: |
Internal medicine journal - 54(2024), 1 vom: 24. Jan., Seite 183-186 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Al Naji, Hiba [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Antiviral Agents |
|---|
| Anmerkungen: |
Date Completed 26.01.2024 Date Revised 26.01.2024 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.1111/imj.16254 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM367578034 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM367578034 | ||
| 003 | DE-627 | ||
| 005 | 20240126232201.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240125s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1111/imj.16254 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1271.xml |
| 035 | |a (DE-627)NLM367578034 | ||
| 035 | |a (NLM)38267381 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Al Naji, Hiba |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Prescribing of antivirals for COVID-19 in a South Australian local health network according to statewide guidelines |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 26.01.2024 | ||
| 500 | |a Date Revised 26.01.2024 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2023 Royal Australasian College of Physicians. | ||
| 520 | |a Antiviral drugs were rapidly implemented into clinical practice for the treatment of high-risk patients with COVID-19, prompting the development of statewide guidelines. This South-Australian study reviewed guideline adherence, assessed prescribing patterns and highlighted the inappropriate management of relative drug-drug interactions and dosing for renal function. Additionally, it evaluated the impact of inappropriate antiviral drug use and suggested methods to improve quality use of medicines | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a living guidelines | |
| 650 | 4 | |a molnupiravir | |
| 650 | 4 | |a nirmatrelvir/ritonavir | |
| 650 | 4 | |a prescribing | |
| 650 | 4 | |a remdesivir | |
| 650 | 7 | |a Antiviral Agents |2 NLM | |
| 700 | 1 | |a Inglis, Joshua M |e verfasserin |4 aut | |
| 700 | 1 | |a Tucker, Emily |e verfasserin |4 aut | |
| 700 | 1 | |a Rowett, Debra |e verfasserin |4 aut | |
| 700 | 1 | |a Larcombe, Rebecca |e verfasserin |4 aut | |
| 700 | 1 | |a Medlin, Sophie |e verfasserin |4 aut | |
| 700 | 1 | |a Mangoni, Arduino A |e verfasserin |4 aut | |
| 700 | 1 | |a Thynne, Tilenka |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Internal medicine journal |d 2001 |g 54(2024), 1 vom: 24. Jan., Seite 183-186 |w (DE-627)NLM113582811 |x 1445-5994 |7 nnns |
| 773 | 1 | 8 | |g volume:54 |g year:2024 |g number:1 |g day:24 |g month:01 |g pages:183-186 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1111/imj.16254 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 54 |j 2024 |e 1 |b 24 |c 01 |h 183-186 | ||